BioCer Entwicklungs

BioCer Entwicklungs is a German medical technology company focused on developing, manufacturing, and distributing biomaterial-based medical devices that do not contain animal or human components. Its commercial portfolio centers on plant-based haemostatic products, surgical mesh implants for hernia and breast surgery, and functional implant coatings designed to improve biocompatibility, osteoconductivity, antibacterial performance, or allergy compatibility. The company was founded as a spin-off of the University of Bayreuth and has built in-house capabilities spanning development, regulatory approval, production, and global distribution. BioCer also acts as a research and development partner and contract manufacturer for medical technology products. Its products are marketed internationally through a distributor network reaching roughly 80 countries.